Oxalic Acid

Oxalic Acid

SCHEMBL17835689

CN(C)CC[C@H](O)c1ccccc1.O=C(O)C(=O)O

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 2/20 0.58
HRH1 P35367 2/20 0.58
KDM4E B2RXH2 4/20 0.49
KMT2A Q03164 4/20 0.49
MEN1 O00255 3/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
RIPK1 Q13546 1/20 0.49
AOC3 Q16853 1/20 0.49
LMNA P02545 2/20 0.47
ALDH1A1 P00352 1/20 0.47
CYP3A4 P08684 1/20 0.47
TSHR P16473 1/20 0.47
CYP2C19 P33261 1/20 0.47
RAB9A P51151 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1534201 0.93 HTR2A (0.67) HTR2AHRH1KDM4ESMN1; SMN2RIPK1
SCHEMBL1534311 0.93 HTR2A (0.67) HTR2AHRH1KDM4ESMN1; SMN2RIPK1
SCHEMBL1534343 0.93 HTR2A (0.67) HTR2AHRH1KDM4ESMN1; SMN2RIPK1
Hydrochloric Acid SCHEMBL4377637 0.91 HTR2A (0.64) HTR2AHRH1KDM4ESMN1; SMN2RIPK1
Mandelic Acid SCHEMBL8500671 0.88 LMNA (0.58) HTR2AHRH1KDM4ERIPK1AOC3
Mandelic Acid SCHEMBL8022884 0.88 LMNA (0.58) HTR2AHRH1KDM4ERIPK1AOC3
SCHEMBL527127 0.86 KDM4E (0.49) HTR2AHRH1KDM4EKMT2AMEN1
SCHEMBL6893002 0.86 KDM4E (0.49) HTR2AHRH1KDM4EKMT2AMEN1
SCHEMBL5610068 0.83 HTR2A (0.71) HTR2AHRH1KDM4ESMN1; SMN2RIPK1
SCHEMBL19399095 0.82 AOC3 (0.49) HTR2AHRH1KDM4EKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190046515-A1 AMIDO THIADIAZOLE DERIVATIVES AS NADPH OXIDASE INHIBITORS GENKYOTEX SA (CH) 2019-02-14 US disclosed
US-10130619-B2 Amido thiadiazole derivatives as NADPH oxidase inhibitors GENKYOTEX SUISSE SA (CH) 2018-11-20 US disclosed
US-20170348296-A1 AMIDO THIADIAZOLE DERIVATIVES AS NADPH OXIDASE INHIBITORS GENKYOTEX SUISSE SA (CH) 2017-12-07 US disclosed
EP-3233847-A1 AMIDO THIADIAZOLE DERIVATIVES AS NADPH OXIDASE INHIBITORS GenKyoTex Suisse SA (CH) 2017-10-25 EP disclosed
WO-2016098005-A1 AMIDO THIADIAZOLE DERIVATIVES AS NADPH OXIDASE INHIBITORS GENKYOTEX SA (CH) 2016-06-23 WO disclosed
EP-3034500-A1 Amido thiazole derivatives as NADPH oxidase inhibitors GENKYOTEX SA (CH) 2016-06-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170348296-A1 AMIDO THIADIAZOLE DERIVATIVES AS NADPH OXIDASE INHIBITORS NOX1, NOX5, CYBB HTR2A 4176/4885HRH1 942/4885KDM4E 4240/4885
US-20190046515-A1 AMIDO THIADIAZOLE DERIVATIVES AS NADPH OXIDASE INHIBITORS NOX1, NOX5, CYBB HTR2A 4176/4885HRH1 942/4885KDM4E 4240/4885
US-10130619-B2 Amido thiadiazole derivatives as NADPH oxidase inhibitors NOX1, NOX5, CYBB HTR2A 4176/4885HRH1 942/4885KDM4E 4240/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.